[1]
Limardo, M. and Pontoriero, G. 2017. Etelcalcetide: A New Intravenous Calcimimetic for the Treatment of Secondary Hyperparathyroidism in Haemodialysis Patients. Giornale di Clinica Nefrologica e Dialisi. 29, 1 (Feb. 2017), 62–65. DOI:https://doi.org/10.33393/gcnd.2017.623.